Related Experiment Video
Updated: Jan 14, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Erdheim-Chester Disease Masquerading as Leukemia: Outwitting the Need for Transplant
William A Ketterer1, Joshua Scott2, Zachary Gillooly3
1Internal Medicine, Wright State University, Dayton, USA.
Erdheim-Chester disease (ECD) is a rare histiocytosis. This case highlights a RAS-positive ECD with atypical symptoms, successfully managed with MEK inhibition targeting the KRAS pathway.
Area of Science:
- Histiocytosis and rare neoplasms
- Oncology and hematology
- Molecular diagnostics in rare diseases
Background:
- Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by histiocyte infiltration across multiple organs.
- Clinical presentation of ECD is highly variable, depending on the affected organ systems, including bones, CNS, skin, kidneys, and vasculature, making diagnosis challenging.
- KRAS mutations, while less common than BRAF mutations, are identified in a subset of ECD cases.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Kidney Transplant I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...